$1.21
-0.01-0.82%
Last update: Oct 30, 4:00 PM
Alzamend Neuro Inc (ALZN) Stock Price, Quote, News & History
ALZNNASDAQ
Analysts changed outlook on top names. Piper Sandler raises Mercury Systems' target price, Ascendiant Capital boosts Alzamend Neuro's target price, BTIG...
You can purchase shares of Alzamend Neuro (NASDAQ:ALZN) through any online brokerage.
Other companies in Alzamend Neuro’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Alzamend Neuro has a consensus price target of $26.00.
The stock price for Alzamend Neuro (NASDAQ: ALZN) is $1.16 last updated October 27, 2026 at 9:00 AM EDT.
There are no upcoming dividends for Alzamend Neuro.
Alzamend Neuro does not have any upcoming earnings scheduled.
There is no upcoming split for Alzamend Neuro.
Alzamend Neuro is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's disease. The Company has two therapeutic...
